Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system

被引:329
作者
Amidi, M
Romeijn, SG
Borchard, G
Junginger, HE
Hennink, WE
Jiskoot, W
机构
[1] Univ Utrecht, Dept Pharmaceut, UIPS, NL-3508 TB Utrecht, Netherlands
[2] Leiden Univ, Dept Pharmaceut Technol, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
N-trimethyl chitosan nanoparticles; nasal protein delivery; Calu-3; cells; ciliary beat frequency;
D O I
10.1016/j.jconrel.2005.11.014
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study, the potential of N-trimethyl chitosan (TMC) nanoparticles as a carrier system for the nasal delivery of proteins was investigated. TMC nanoparticles were prepared by ionic crosslinking of TMC solution (with or without ovalbumin) with tripolyphosphate, at ambient temperature while stirring. The size, zeta-potential and morphology of the nanoparticles were investigated as a function of the preparation conditions. Protein loading, protein integrity and protein release were studied. The toxicity of the TMC nanoparticles was tested by ciliary beat frequency measurements of chicken embryo trachea and in vitro cytotoxicity assays. The in vivo uptake of FITC-albumin-loaded TMC nanoparticles by nasal epithelia tissue in rats was studied by confocal laser scanning microscopy. The nanoparticles had an average size of about 350 nm and a positive zeta-potential. They showed a loading efficiency up to 95% and a loading capacity up to 50% (w/w). The integrity of the entrapped ovalbumin was preserved. Release studies showed that more than 70% of the protein remained associated with the TMC nanoparticles for at least 3 h on incubation in PBS (pH 7.4) at 37 degrees C. Cytotoxicity tests with Calu-3 cells showed no toxic effects of the nanoparticles, whereas a partially reversible cilio-inhibiting effect on the ciliary beat frequency of chicken trachea was observed. In vivo uptake studies indicated the transport of FITC-albumin-associated TMC nanoparticles across the nasal mucosa. In conclusion, TMC nanoparticles are a potential new delivery system for transport of proteins through the nasal mucosa. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 60 条
  • [1] Nasal delivery of vaccines
    Almeida, AJ
    Alpar, HO
    [J]. JOURNAL OF DRUG TARGETING, 1996, 3 (06) : 455 - 467
  • [2] Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers
    Aspden, TJ
    Mason, JDT
    Jones, NS
    Lowe, J
    Skaugrud, O
    Illum, L
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) : 509 - 513
  • [3] Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system
    Baudner, BC
    Morandi, M
    Giuliani, MM
    Verhoef, JC
    Junginger, HE
    Costantino, P
    Rappuoli, R
    Del Giudice, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) : 828 - 832
  • [4] The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
    Baudner, BC
    Giuliani, MM
    Verhoef, JC
    Rappuoli, R
    Junginger, HE
    Del Giudice, G
    [J]. VACCINE, 2003, 21 (25-26) : 3837 - 3844
  • [5] Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles:: preparation, characterization, and preliminary in vivo studies
    Bivas-Benita, M
    Laloup, M
    Versteyhe, S
    Dewit, J
    De Braekeleer, J
    Jongert, E
    Borchard, G
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 266 (1-2) : 17 - 27
  • [6] The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
    Borchard, G
    Luessen, HL
    deBoer, AG
    Verhoef, JC
    Lehr, CM
    Junginger, HE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) : 131 - 138
  • [7] Transport of nanoparticles across the rat nasal mucosa
    Brooking, J
    Davis, SS
    Illum, L
    [J]. JOURNAL OF DRUG TARGETING, 2001, 9 (04) : 267 - 279
  • [8] Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
  • [9] 2-4
  • [10] Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
    Calvo, P
    RemunanLopez, C
    VilaJato, JL
    Alonso, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (10) : 1431 - 1436